NasdaqGS - Delayed Quote USD
Quince Therapeutics, Inc. (QNCX)
1.4300
+0.2300
+(19.17%)
At close: June 13 at 4:00:00 PM EDT
1.3500
-0.08
(-5.59%)
Pre-Market: 8:07:42 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-33,152
-31,904
-18,292
-44,038
-62,932
Investing Cash Flow
23,892
21,908
-5,758
18,002
58,952
Financing Cash Flow
-4,878
-4,775
143
707
6,808
End Cash Position
7,675
6,212
20,752
44,579
69,724
Capital Expenditure
-366
-257
-160
-133
-180
Issuance of Capital Stock
608
--
0
608
0
Repayment of Debt
-31
0
-6
-49
0
Free Cash Flow
-33,518
-32,161
-18,452
-44,171
-63,112
12/31/2021 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLGL Sol-Gel Technologies Ltd.
7.52
+8.99%
ALZN Alzamend Neuro, Inc.
3.2400
+1.57%
EQ Equillium, Inc.
0.3470
-10.22%
ONCO Onconetix, Inc.
4.7300
-24.90%
TNFA TNF Pharmaceuticals, Inc.
0.1370
-10.57%
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
JUNS Jupiter Neurosciences, Inc.
1.1300
+0.89%
RENB Renovaro Inc.
0.3653
-3.77%
PALI Palisade Bio, Inc.
0.6401
-7.23%
PRQR ProQR Therapeutics N.V.
1.8800
-3.09%